Analytical Method Development & Validation CROs in India
8 published
8 published CROs match Analytical Method Development & Validation in India.
Facilities in this set are in Hyderabad, Bengaluru, Mumbai, Pune, Ankleshwar, and Jaipur.
Capabilities that show up most often in this set: Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Oligonucleotide, and Antibody-Drug Conjugate (ADC).
Matching companies
ACM Global LaboratoriesGlobal clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.
Accutest Research LaboratoriesIndependent Indian CRO since 1998 offering BA/BE studies, clinical development (Phase II–IV), and biologics testing to pharmaceutical and biotech companies. Facilities in Mumbai and Vadodara include 21 LC-MS/MS systems and 262 clinical beds.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Novick BiosciencesOverview Novick Biosciences describes itself as a strategic research partner for pharmaceutical companies, with a stated focus on flexible, innovative, and problem-solving models.
PI Health SciencesPI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.
Sapala OrganicsSapala Organics is a nucleic acid chemistry CRO and CDMO offering custom synthesis of oligonucleotide building blocks, oligo-based drug development and manufacturing, and orthogonal analytical services. The company is now a subsidiary of Cohance Lifesciences.
Sparge Chem Pvt. Ltd.Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /services/analytical-development/india.md